All Videos Channels
  1. Regulatory Affairs - Global Regulatory Harmonization for drugs & medical devices- IMDRF and ICMRA. Peivand Pirouzi, Ph.D.

    Regulatory Affairs - Global Regulatory Harmonization for drugs & medical devices- IMDRF and ICMRA. Peivand Pirouzi, Ph.D.

    38
  2. Regulatory Affairs - Health Canada CTA in CTD fromat - Completing the clinical trial attestation form. Peivand Pirouzi, Ph.D.

    Regulatory Affairs - Health Canada CTA in CTD fromat - Completing the clinical trial attestation form. Peivand Pirouzi, Ph.D.

    37
  3. Regulatory Affairs - Health Canada Form-0292-Medical Devices Establishment Licensing (MDEL) Application. P.Pirouzi, Ph.D.

    Regulatory Affairs - Health Canada Form-0292-Medical Devices Establishment Licensing (MDEL) Application. P.Pirouzi, Ph.D.

    13
  4. Healthcare Regulatory Affairs Outsourcing Market Business Scenario.

    Healthcare Regulatory Affairs Outsourcing Market Business Scenario.

    14
  5. Regulatory Affairs - Health Canada CTA in CTD format - Completing the clinical trial site information form. Peivand Pirouzi, Ph.D.

    Regulatory Affairs - Health Canada CTA in CTD format - Completing the clinical trial site information form. Peivand Pirouzi, Ph.D.

    33
  6. Regulatory Affairs - Completion of Health Canada form PSEAT for CTA application. Peivand Pirouzi, Ph.D.

    Regulatory Affairs - Completion of Health Canada form PSEAT for CTA application. Peivand Pirouzi, Ph.D.

    28
  7. Regulatory Affairs - eCTD Submission Gateways for FDA and EMA, and ICH-M8 (Pharmaceutical Sciences and Health Care products). Peivand Pirouzi, Ph.D.

    Regulatory Affairs - eCTD Submission Gateways for FDA and EMA, and ICH-M8 (Pharmaceutical Sciences and Health Care products). Peivand Pirouzi, Ph.D.

    24
    1
  8. Regulatory Affairs - Health Canada Clinical Trial Application CTA in CTD format - Completing form 3011. P.Pirouzi, Ph.D.

    Regulatory Affairs - Health Canada Clinical Trial Application CTA in CTD format - Completing form 3011. P.Pirouzi, Ph.D.

    35
  9. Regulatory Affairs - EMA - Marketing Authorization Applications for Pharmaceutical Products in EU. Peivand Pirouzi, Ph.D.

    Regulatory Affairs - EMA - Marketing Authorization Applications for Pharmaceutical Products in EU. Peivand Pirouzi, Ph.D.

    33
  10. Trump Accuses "Comrade Kamala" of "Regulatory Jihad"

    Trump Accuses "Comrade Kamala" of "Regulatory Jihad"

    2
    0
    22
  11. Regulatory Affairs - FDA databases: Drugs@FDA and Clinical trials.gov - Live demonstrations - Peivand Pirouzi, Ph.D.

    Regulatory Affairs - FDA databases: Drugs@FDA and Clinical trials.gov - Live demonstrations - Peivand Pirouzi, Ph.D.

    24
  12. Regulatory Affairs Project Management: NDS in CTD Format for Health Canada by Peivand Pirouzi, Ph.D.

    Regulatory Affairs Project Management: NDS in CTD Format for Health Canada by Peivand Pirouzi, Ph.D.

    45
  14. Regulatory Affairs - Clinical Trials Information System in Europe (EMA-Clinical Research). Peivand Pirouzi, Ph.D.

    Regulatory Affairs - Clinical Trials Information System in Europe (EMA-Clinical Research). Peivand Pirouzi, Ph.D.

    19
  15. Senate Banking Housing and Urban Affairs Committee: Recent Bank Failures and the Federal Regulatory Response - March 28, 2023

    Senate Banking Housing and Urban Affairs Committee: Recent Bank Failures and the Federal Regulatory Response - March 28, 2023

    6
  16. HEARING: Economic Growth Energy Policy and Regulatory Affairs

    HEARING: Economic Growth Energy Policy and Regulatory Affairs

    2
  17. Regulatory Affairs - Health Canada-Preparation of Meeting Application Packages for CTA,NDS,SNDS. Peivand Pirouzi, Ph.D.

    Regulatory Affairs - Health Canada-Preparation of Meeting Application Packages for CTA,NDS,SNDS. Peivand Pirouzi, Ph.D.

    35
  18. Regulatory Affairs and Quality Assurance - Pharmaceutical Inspections and Audits (Based on ICH-Q10). Peivand Pirouzi, Ph.D.

    Regulatory Affairs and Quality Assurance - Pharmaceutical Inspections and Audits (Based on ICH-Q10). Peivand Pirouzi, Ph.D.

    29